114 related articles for article (PubMed ID: 20586836)
1. Alopecia areata as another immune-mediated disease developed in patients treated with tumour necrosis factor-α blocker agents: Report of five cases and review of the literature.
Ferran M; Calvet J; Almirall M; Pujol RM; Maymó J
J Eur Acad Dermatol Venereol; 2011 Apr; 25(4):479-84. PubMed ID: 20586836
[TBL] [Abstract][Full Text] [Related]
2. [Alopecia areata during anti-TNF alpha therapy: Nine cases].
Le Bidre E; Chaby G; Martin L; Perrussel M; Sassolas B; Sigal ML; Kaassis C; Lespessailles E; Nseir A; Estève E
Ann Dermatol Venereol; 2011; 138(4):285-93. PubMed ID: 21497255
[TBL] [Abstract][Full Text] [Related]
3. Alopecia areata during etanercept therapy.
Pan Y; Rao NA
Ocul Immunol Inflamm; 2009; 17(2):127-9. PubMed ID: 19412875
[TBL] [Abstract][Full Text] [Related]
4. Alopecia areata universalis during off-label treatment with Infliximab in a patient with Behçet disease.
Beccastrini E; Squatrito D; Emmi G; Fabbri P; Emmi L
Dermatol Online J; 2010 Sep; 16(9):15. PubMed ID: 20875336
[TBL] [Abstract][Full Text] [Related]
5. Alopecia areata following adalimumab.
Kirshen C; Kanigsberg N
J Cutan Med Surg; 2009; 13(1):48-50. PubMed ID: 19298772
[TBL] [Abstract][Full Text] [Related]
6. Recurrence of alopecia areata in a patient receiving etanercept injections.
Posten W; Swan J
Arch Dermatol; 2005 Jun; 141(6):759-60. PubMed ID: 15967923
[TBL] [Abstract][Full Text] [Related]
7. Immune-mediated skin lesions in patients treated with anti-tumour necrosis factor alpha inhibitors.
Exarchou SA; Voulgari PV; Markatseli TE; Zioga A; Drosos AA
Scand J Rheumatol; 2009; 38(5):328-31. PubMed ID: 19579151
[TBL] [Abstract][Full Text] [Related]
8. Alopecia areata during treatment of psoriasis with adalimumab and leflunomide: a case and review of the literature.
Navarro R; Daudén E; Gallo E; Santiago Sánchez-Mateos D; García-Diez A
Skin Pharmacol Physiol; 2012; 25(2):107-10. PubMed ID: 22301842
[TBL] [Abstract][Full Text] [Related]
9. Adalimumab-induced psoriatic alopecia/alopecia areata-like reaction in a patient with Crohn's disease.
Toda-Brito H; Lopes L; Soares-Almeida L; Filipe P
Dermatol Online J; 2015 Nov; 21(11):. PubMed ID: 26632930
[TBL] [Abstract][Full Text] [Related]
10. Alopecia areata during treatment with adalimumab: therapy with an alternative TNF-alpha inhibitor is possible.
Zschoche C; Bidier M; Hadaschik E
J Dtsch Dermatol Ges; 2013 May; 11(5):450-3. PubMed ID: 23279686
[No Abstract] [Full Text] [Related]
11. Resident Rounds. Part III B: tumor necrosis factor-α antagonists and alopecia areata: a class-wide adverse effect.
Griffith JL; Ledet JJ; Elewski BE
J Drugs Dermatol; 2013 Jun; 12(6):713-4. PubMed ID: 23839195
[No Abstract] [Full Text] [Related]
12. Etanercept does not effectively treat moderate to severe alopecia areata: an open-label study.
Strober BE; Siu K; Alexis AF; Kim G; Washenik K; Sinha A; Shupack JL
J Am Acad Dermatol; 2005 Jun; 52(6):1082-4. PubMed ID: 15928633
[TBL] [Abstract][Full Text] [Related]
13. Worsening alopecia areata and de novo occurrence of multiple halo nevi in a patient receiving infliximab.
Fabre C; Dereure O
Dermatology; 2008; 216(2):185-6. PubMed ID: 18216487
[No Abstract] [Full Text] [Related]
14. Alopecia areata in a patient receiving infliximab.
Ormaechea-Pérez N; López-Pestaña A; Muñagorri-Santos AI; Moreno AJ; Tuneu-Valls A
Indian J Dermatol Venereol Leprol; 2013; 79(4):529-31. PubMed ID: 23760327
[No Abstract] [Full Text] [Related]
15. The progressive state, in contrast to the stable or regressive state of alopecia areata, is reflected in peripheral blood mononuclear cells.
Zöller M; McElwee KJ; Vitacolonna M; Hoffmann R
Exp Dermatol; 2004 Jul; 13(7):435-44. PubMed ID: 15217364
[TBL] [Abstract][Full Text] [Related]
16. Development of alopecia areata after biological therapy with TNF-alpha Blockers: description of a case and review of the literature.
Hernández MV; Nogués S; Ruiz-Esquide V; Alsina M; Cañete JD; Sanmartí R
Clin Exp Rheumatol; 2009; 27(5):892-3. PubMed ID: 19917182
[No Abstract] [Full Text] [Related]
17. Alopecia areata universalis complicating daclizumab therapy for uveitis.
Rosenstein AK; Machler BC; Rosenstein ED
Cutis; 2014 May; 93(5):E13-6. PubMed ID: 24897146
[TBL] [Abstract][Full Text] [Related]
18. Alopecia areata in a patient using infliximab: new insights into the role of tumor necrosis factor on human hair follicles.
Ettefagh L; Nedorost S; Mirmirani P
Arch Dermatol; 2004 Aug; 140(8):1012. PubMed ID: 15313825
[No Abstract] [Full Text] [Related]
19. Alopecia areata occurring during anti-TNF therapy: a national multicenter prospective study.
Tauber M; Buche S; Reygagne P; Berthelot JM; Aubin F; Ghislain PD; Cohen JD; Coquerelle P; Goujon E; Jullien D; Brixi H; Jeudy G; Guennoc X; Martin A; Brénaut E; Hoppé E; Bertolotti A; Bardin T; Delaporte E; Allez M; Bachelez H; Seneschal J; Viguier M; ; ;
J Am Acad Dermatol; 2014 Jun; 70(6):1146-9. PubMed ID: 24831323
[No Abstract] [Full Text] [Related]
20. Anti-tumor necrosis factor alpha therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: a followup report of tolerability and efficacy.
Gottenberg JE; Merle-Vincent F; Bentaberry F; Allanore Y; Berenbaum F; Fautrel B; Combe B; Durbach A; Sibilia J; Dougados M; Mariette X
Arthritis Rheum; 2003 Jul; 48(7):2019-24. PubMed ID: 12847696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
